This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Mammography World Markets

5. Mammography: An Overview 66

5.1 Screen-Film Mammography 66

5.2 2D Digital Mammography 67

5.3 3D Digital Mammography 68

5.3.1 Better Visualization in 3D Images 70 3D Imaging and Superimposed Breast Tissue 71 Status of Tomosynthesis 72 Other Companies Working on Digital Breast Tomosynthesis (DBT) 73 Features of Hologic Tomosynthesis Unit 73 GE Tomosynthesis 73 Siemens Tomosynthesis 73 Philips (Sectra) Tomosynthesis 73

5.3.2 Difference between 3D and 2D Digital Mammography 74 Comparative Merits of Digital and Film-Screen Mammography 74

5.4 Basic Physics of Mammography 75

5.4.1 Mammography X-Ray Tubes 75

5.4.2 Mammography Image Receptors 77

5.4.3 Mammography AEC 79

5.4.4 Mammography Scatter Reduction 79

5.4.5 Differences in Dose Levels among Digital Mammography Systems 79

5.4.6 The Irish Study 79

5.4.7 Patient Radiation Doses in Swedish Screening Program 80

5.5 Points to be Considered Before Buying a Mammography System 81

5.6 Cost Containment in Mammography Systems 82

6. Screening Mammography Data from Selected Countries 846.1 U.S. Data on Screening Mammography 846.1.1 Prevalence of Mammography in the U.S. 846.1.2 Drop in U.S. Mammography Rates 846.1.3 Guidelines for Screening Mammography in the U.S. 856.1.4 Crisis in U.S. Mammography Services 856.1.5 Current Mammography Use in the U.S. 876.2 Organized Screening Programs in Canada 896.2.1 Early Detection of Breast Cancer in Canada 896.2.2 Distribution of Breast Cancer Detected during Screening by Stage in Canada 916.2.3 Newly Diagnosed Women with Her2+ by Province in Canada 916.2.4 Breast Cancer Treatment after Diagnosis in Canada 926.2.5 Radiation Therapy after Diagnosis in Canada 936.2.6 Chemotherapy after Breast Cancer Screening in Canada 936.2.7 Screening Mammography in British Colombia (BC) 946.2.7.1 Annual Screening Volume in BC 946.2.7.2 Bilateral Mammography Utilization in BC 966.2.7.3 Histologic Features of Breast Cancers Detected by SMP in BC 966.3 European Data on Screening Mammography 966.3.1 Screening Mammography Rates in OECD Countries 1006.3.2 Screening Mammography in the U.K. 1026.3.3 Screening Activity in the U.K. 1026.3.4 Acceptance of Screening Invitation by Age—All Invitation Types in the U.K. 1026.3.5 Acceptance by Type of Screen in the U.K. 1036.3.6 Screening Quality—First Screen after First Invitation in the U.K. 1036.3.7 Screening Quality—Subsequent Screening in the U.K. 1036.3.8 Screening—Women Aged 71 and Over in the U.K. 1046.3.9 Assessment Outcomes—Age 50-70 in the U.K. 1046.3.10 Assessment Outcomes—Age 45-74 in the U.K. 1056.3.11 Treatment of Screen Detected Breast Cancer in the U.K. 1056.3.12 Immediate Reconstruction after Mastectomy in the U.K. 1066.4 Screening Mammography in Korea 1076.5 Screening Mammography in Japan 1076.6 National Mammography Screening Program in Israel, 2010 1086.7 Mammography in Australia 1096.7.1 MBS-Funded Mammography in 2011 1106.7.2 Differences in Mammography Services by Age in Australia 1116.7.3 Hospitalizations for Female Breast Cancer in Australia 1116.7.4 Most Commonly Undertaken Female Breast Cancer Procedures in Australia 112

7. Mammography: Market Analysis 113

4 of 14

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs